Range Cancer Therapeutics ETF
(NASDAQ:CNCR)
$15.59
1.11[7.67%]
At close: Apr 15
$15.59
0[0.00%]
After Hours: 9:25AM EDT
OverviewNewsDividendsShort Interest

Range Cancer Therapeutics ETF (NASDAQ:CNCR), Quotes and News Summary

Range Cancer Therapeutics ETF (NASDAQ: CNCR) stock price, news, charts, stock research, profile.

Open$14.525
Close$14.230
Volume / Avg.2.207K / 37.442K
Day Range14.230 - 14.525
52 Wk Range9.220 - 17.960
Market Cap-
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest-
Days to Cover1

Recent News

3 ETFs For More Moderna Bets
Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.
ETF Professor
Hone In On Health Care In China With This New ETF
ETF Professor

FAQ

Q

How do I buy Range Cancer Therapeutics ETF (CNCR) stock?

A

You can purchase shares of Range Cancer Therapeutics ETF (NASDAQ: CNCR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Range Cancer Therapeutics ETF's (CNCR) competitors?

A

There are no as such competitors for Range Cancer Therapeutics ETF.

Q

What is the target price for Range Cancer Therapeutics ETF (CNCR) stock?

A

There is no analysis for Range Cancer Therapeutics ETF.

Q

Current Stock Price for Range Cancer Therapeutics ETF (CNCR)?

A

The stock price for Range Cancer Therapeutics ETF (NASDAQ: CNCR) is $15.59 last updated April 15, 2024 at 9:25 AM EDT.

Q

Does Range Cancer Therapeutics ETF (CNCR) pay a dividend?

A

A quarterly cash dividend of $0.35 per share of Class A Common Stock. The quarterly cash dividend was payable on January 2, 2018 to stockholders of record on December 28, 2017.

Q

When is Range Cancer Therapeutics ETF (NASDAQ:CNCR) reporting earnings?

A

Range Cancer Therapeutics ETF does not have any upcoming earnings scheduled.

Q

Is Range Cancer Therapeutics ETF (CNCR) going to split?

A

There is no upcoming split for Range Cancer Therapeutics ETF.